Component extraction and component identification process of emblic leafflower fruit water-soluble small molecules
Through water-elevating and increasing concentration ethanol precipitation technology and UPLC-Q-Exactive-Orbitrap-MS/MS technology, water-soluble small molecules of yoglucose were successfully extracted and identified, and their antibacterial activity was found, which solved the failure to be effective in the prior art. Exploring the problem of antibacterial effects provides basic support for the study of pharmacokinetics and pharmacodynamics.
Patent Information
- Application Number
- CN202410967023.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-18
- Publication Date
- 2024-11-19
AI Technical Summary
The prior art has failed to effectively explore the antibacterial effects and related components analysis of the water-soluble small molecules of yogurt, and is limited to preliminary extracts, and has failed to detect its antibacterial activity.
Water-elevated and increased concentration ethanol precipitation technology was used to extract water-soluble small molecules of repellent glycol, and the identification was carried out through UPLC-Q-Exactive-Orbitrap-MS/MS technology combined with multiple databases, and chromatographic and mass spectrometry conditions were optimized to achieve efficient separation and identification.
The water-soluble small molecules of Yuganzi have antibacterial biological activity and accurately identified a variety of compounds, including organic acids, flavonoids, polyphenols, etc., providing basic data for pharmacokinetics and pharmacodynamics and efficacy research, supporting clinical application.
Smart Images

Figure CN118976055A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of natural plant chemistry, and in particular to a component extraction and component identification process of water-soluble small molecules of emblica emblica. Background Art
[0002] The Tibetan medicine Phyllanthus emblica L. is the dried fruit of the Euphorbiaceae plant Phyllanthus emblica L., and its Tibetan name is Jurula. The Tibetan Medicine Records records that it is sweet, sour, and astringent in nature, and has the effects of removing dampness and resolving phlegm, cooling blood and clearing heat, promoting body fluid and relieving cough. It can treat liver disease, gallbladder disease, indigestion, eye disease, and bacon, red bark and other diseases. Phyllanthus emblica L. is rich in various tannins, organic acids and flavonoids. Modern research has found that its water extract can improve the glucose and lipid metabolism, liver function, and insulin resistance of diabetic rats, can effectively inhibit the growth of colon cancer, and has strong antioxidant capacity.
[0003] Existing extracts of Phyllanthus emblica for antibacterial purposes are mainly alcohol extracts, essential oils, and polysaccharides, and are limited to preliminary extracts, without exploring the specific active chemical small molecules of their antibacterial effects. At the same time, there are currently no reports on the extraction of water-soluble small molecules of Phyllanthus emblica and analysis of related components. In response to the above problems, the inventors proposed a component extraction and component identification process of water-soluble small molecules of Phyllanthus emblica, detected the antibacterial activity and analyzed and identified its components, in order to solve the above problems. Summary of the invention
[0004] In order to solve the above technical problems, the present invention adopts the following technical scheme: a component extraction and component identification process of water-soluble small molecules of Phyllanthus emblica, comprising the following steps:
[0005] S1. Pretreatment of Phyllanthus emblica fruit
[0006] The fruit of Phyllanthus emblica was crushed, weighed, added with ultrapure water at a ratio of 1 g:10 mL, heated for water extraction, centrifuged, and filtered through a membrane;
[0007] S2. Extraction of water-soluble small molecules from Phyllanthus emblica
[0008] Add high concentration anhydrous ethanol to the supernatant after centrifugal filtration, seal and let stand overnight at 4°C, centrifuge and filter the alcohol precipitated sample, heat and evaporate to remove ethanol and water, add ultrapure water again according to the volume of the original water extract, stir and heat to dissolve, filter through the membrane to obtain the water-soluble small molecule extract of Phyllanthus emblica, and refrigerate at 4°C.
[0009] Preferably, the analysis of the water-soluble small molecule extract of Phyllanthus emblica consists of the following steps:
[0010] A1. Antibacterial function analysis
[0011] The water-soluble small molecule extract was diluted twice with LB liquid medium for later use. After activating the strain by streaking on LB solid plate, a single colony was picked and transferred to 0.9% saline solution. The concentration of the bacterial solution was adjusted to 0.5 McFarland concentration (1.5×10 8 CFU / mL), diluted 100 times, added the diluted bacterial solution to each diluted concentration solution in a 96-well plate, repeated 3 times in each group, with LB medium as blank control, shaken slightly and cultured at 37℃ for 18-24 hours, observed bacterial growth, and compared OD before and after culture. 600 Value changes;
[0012] A2. Identification of components of water-soluble small molecule extracts from Phyllanthus emblica
[0013] Chromatographic conditions: A Waters ACQUITYTM Premier HSS T3 column with specifications of 2.1 mm × 100 mm, 1.8 μm was used; 0.1% formic acid aqueous solution was used as mobile phase A, and methanol was used as mobile phase B for gradient elution;
[0014] Positive ion mode: 0-12 min, 0%-3% B; 12-17 min, 3%-40% B; 17-25 min, 40%-45% B; 25-30 min, 45%-65% B; 30-40 min, 65%-100% B; 40-45 min, 100%-0% B;
[0015] Negative ion mode: 0-18 min, 0%-5% B; 18-20 min, 5%-40% B; 20-25 min, 40%-42% B; 25-30 min, 42%-100% B; 30-35 min, 100-0% B; flow rate 0.3 mL / min, column temperature 30°C, injection volume 3 μL; the above concentrations are all volume percentages;
[0016] Mass spectrometry conditions: ESI electrospray ion source was used, nitrogen was used as drying, nebulizing and collision gas, data were collected in positive and negative ion modes, and the acquisition conditions for both modes were ion source temperature of 350°C, capillary temperature of 320°C, spray voltage of 3.8 kV, sheath gas flow rate of 30 L / h, auxiliary gas flow rate of 15 L / h, capillary voltage of 35 V, tube lens voltage of 110 V, primary resolution of 70000, secondary resolution of 17500, stepped NCE 20, 40, 60, and the mass range of m / z 50-1500 was scanned in MS and MS / MS modes to record spectra. Secondary mass spectrometry used data-dependent scanning, and ions of water-soluble small molecular substances of Phyllanthus emblica recorded in multiple literatures were selected for collision-induced dissociation (CID) fragment scanning;
[0017] The data collected by mass spectrometry were analyzed to identify the water-soluble small molecule components of the Tibetan medicine Phyllanthus emblica.
[0018] Preferably, in S1, the centrifugation parameter is 12000g for 60 min to separate and precipitate macromolecular polysaccharides and proteins with greater efficiency.
[0019] Preferably, in S1, water extraction is used for extraction, the ratio of emblica emblica to water is 1 g:10 mL, and the extraction time is 2 h.
[0020] Preferably, in S2, high concentration ethanol precipitation is used to remove macromolecular polysaccharides and proteins, and to extract target emblica water-soluble small molecules.
[0021] Preferably, in A1, the antibacterial properties of the water-soluble small molecule extract of Emblica officinalis were discovered.
[0022] Preferably, in A2, a Waters ACQUITYTM Premier HSS T3 chromatographic column is used to achieve better separation effect.
[0023] Preferably, in A2, the analysis and identification method is:
[0024] Firstly, the data on the chemical components of Phyllanthus emblica were obtained by consulting the literature, and the structures of the chemical components were input into the Compound Discover software to establish a primary database for comparison. At the same time, the Traditional Chinese Medicine Components High Resolution Mass Spectrum Database (OTCML) was imported to establish a local secondary database for secondary fragment comparison. The online search of the primary data resource library ChemSpider and the secondary data resource library MzCloud was combined to analyze and compare the components.
[0025] Then, the accurate mass, mass spectrometry fragments and characteristic fragment ions of the compounds in the HMDB and PMhub databases were used to make judgments and determine the final screening results.
[0026] Compared with the prior art, the present invention has the following beneficial effects:
[0027] 1. In the present invention, water-soluble small molecule chemical components of the Tibetan medicine Phyllanthus emblica are extracted for the first time by using water extraction and high-concentration ethanol precipitation technology;
[0028] 2. In the present invention, the water-soluble small molecule extract was found to have antibacterial biological activity in functional analysis;
[0029] 3. In the present invention, by optimizing the extraction conditions, chromatographic conditions and mass spectrometry conditions of the active ingredients, a method for efficiently separating multiple active ingredients in the positive and negative ion modes was established, and the water-soluble small molecule chemical components in Phyllanthus emblica were systematically and accurately identified using UPLC-Q-Exactive-Orbitrap-MS / MS technology. In combination with multiple databases (ChemSpider, MzCloud, PMhub, OTCML, HMDB), the fragment ion information was compared in the Compound Discover 3.0 data analysis and processing software, thereby improving the accuracy of the identification results. 23 compounds were identified in the positive ion mode, 24 compounds were identified in the negative ion mode, and a total of 43 compounds were identified, including organic acids, flavonoids, polyphenols, tannins, amino acids, purines and other types of compounds, providing data support for further research on the pharmacokinetics and pharmacodynamics of Phyllanthus emblica, and laying a theoretical foundation for clinical application. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0031] Figure 1 This is an experimental chart showing that the water-soluble small molecule extract of Phyllanthus emblica of the present invention inhibits Staphylococcus aureus.
[0032] Figure 2 This is an experimental chart showing that the water-soluble small molecule extract of Phyllanthus emblica of the present invention inhibits Escherichia coli.
[0033] Figure 3 This is an experimental chart showing that the water-soluble small molecule extract of Phyllanthus emblica of the present invention inhibits Pseudomonas aeruginosa.
[0034] Figure 4 The total ion current mass spectrum was collected in the positive ion mode of the present invention.
[0035] Figure 5 The total ion current mass spectrum was collected in the negative ion mode of the present invention. DETAILED DESCRIPTION
[0036] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0037] Example: Figure 1-5 As shown, the present invention provides a component extraction and component identification process of water-soluble small molecules of Phyllanthus emblica, comprising the following steps:
[0038] S1. Pretreatment of Phyllanthus emblica fruit
[0039] The fruit of Phyllanthus emblica was crushed by a grinder, weighed, and ultrapure water was added at a ratio of 1 g: 10 mL. After sealing, the mixture was boiled at 180°C until the surface was boiling. After boiling, the temperature was adjusted to 110°C to 120°C and boiled for 2 hours. During the heating period, the water extract was centrifuged at 12000 rpm for 60 minutes and filtered through a 0.45 μm filter membrane.
[0040] S2. Extraction of water-soluble small molecules from Phyllanthus emblica
[0041] Slowly add anhydrous ethanol (1:8, v / v) to the water extract while stirring until the final ethanol concentration is 87.5%. Seal and let stand overnight at 4°C. Centrifuge the alcohol precipitated sample at 12000g for 60min. Pass the supernatant through a 0.22μm filter membrane and heat to evaporate the ethanol and water. Add ultrapure water again according to the volume of the original water extract, stir and heat to dissolve. Pass the filter membrane through a 0.22μm filter membrane to obtain the water-soluble small molecule extract of Phyllanthus emblica, which is refrigerated at 4°C.
[0042] The analysis of the water-soluble small molecule extract of Phyllanthus emblica consists of the following steps:
[0043] A1. Antibacterial function analysis
[0044] The water-soluble small molecule extract was diluted twice in a gradient manner (50%, 25%, 12.5%, 6.25%, 3.125%, 1.563%, 0.781%) in 96-well plates with LB liquid culture medium for later use;
[0045] After streaking the LB solid plate to activate E.coli, S.aureus, and P.aeruginosa, pick a single colony and transfer it to 0.9% saline. Adjust the bacterial solution concentration to 0.5 McFarland concentration (1.5×108CFU / mL), dilute it 100 times, and add 10μL of the diluted bacterial solution to each diluted concentration solution (volume 200μL) in the 96-well plate. Repeat 3 times in each group, and use LB medium as a blank control. Shake well after slight shaking, culture at 37℃ for 18-24 hours, observe the bacterial growth, and use a microplate reader to compare the changes in OD600 values before and after culture. The antibacterial results are shown in Figure 1 , Figure 2 , Figure 3 ;
[0046] A2. Identification and analysis of water-soluble small molecule components of Phyllanthus emblica
[0047] The water-soluble small molecule extract was filtered through a 0.22 μm filter membrane and then loaded;
[0048] Chromatographic conditions: A Waters ACQUITYTM Premier HSS T3 column with specifications of 2.1 mm × 100 mm, 1.8 μm was used; 0.1% formic acid aqueous solution was used as mobile phase A, and methanol was used as mobile phase B for gradient elution;
[0049] Positive ion mode: 0-12 min, 0%-3% B; 12-17 min, 3%-40% B; 17-25 min, 40%-45% B; 25-30 min, 45%-65% B; 30-40 min, 65%-100% B; 40-45 min, 100%-0% B;
[0050] Negative ion mode: 0-18 min, 0%-5% B; 18-20 min, 5%-40% B; 20-25 min, 40%-42% B; 25-30 min, 42%-100% B; 30-35 min, 100-0% B; flow rate 0.3 mL / min, column temperature 30°C, injection volume 3 μL; the above concentrations are all volume percentages;
[0051] Mass spectrometry conditions: ESI electrospray ion source was used, nitrogen was used as drying, nebulizing and collision gas, data were collected in positive and negative ion modes, and the acquisition conditions for both modes were ion source temperature of 350°C, capillary temperature of 320°C, spray voltage of 3.8 kV, sheath gas flow rate of 30 L / h, auxiliary gas flow rate of 15 L / h, capillary voltage of 35 V, tube lens voltage of 110 V, primary resolution of 70000, secondary resolution of 17500, stepped NCE20, 40, 60;
[0052] The spectra were recorded by scanning the mass range of m / z 50-1500 in MS and MS / MS modes. The secondary mass spectrometry adopted data-dependent scanning. The precise molecular masses of multiple water-soluble small molecules of Phyllanthus emblica were imported from the references. Collision-induced dissociation (CID) fragmentation scanning was performed. The mass spectra of the total ion current changing with time in the positive and negative ion modes were shown in Figure 4 , Figure 5 ;
[0053] CompoundDiscover3.0 was used to analyze the collected mass spectrometry data, and literature was consulted to find the components of Phyllanthus emblica. The chemical formula was entered into PMhub (https: / / pmhub.org.cn / # / ) to search for compound structures and establish a local primary structure library. The high-resolution mass spectrometry database of traditional Chinese medicine ingredients (OTCML) was imported to establish a local secondary library. At the same time, the primary data resource library ChemSpider and the secondary data resource library MzCloud were searched online for analysis, comparison and identification of the components. The details of the analysis and identification results are shown in Tables 1 and 2 below.
[0054]
[0055]
[0056] Table 1: Identification results in positive ion mode
[0057]
[0058]
[0059] Table 2: Negative ion mode identification results
[0060] Among them, the chromatographic instrument uses the ThermoScientific Vanquish UHPLC system;
[0061] The Thermo Fisher Scientific Q Exactive combined quadrupole-Orbitrap mass spectrometer was used;
[0062] Anhydrous ethanol, ultrapure water, LB liquid culture medium, chromatography grade methanol, chromatography grade formic acid, chromatography grade acetonitrile, Staphylococcus aureus 29213 (Staphylococcusaureus), Escherichia coli 25922 (Escherichiacoli), and Pseudomonas aeruginosa 27853 (Pseudomonas aeruginosa) are all experimental grade materials.
[0063] In S1, the centrifugation parameters are 12000g for 60 min to separate and precipitate macromolecular polysaccharides and proteins with greater efficiency.
[0064] In S1, water extraction was used for extraction, the ratio of emblica emblica to water was 1 g:10 mL, and the extraction time was 2 h.
[0065] In S2, high concentration ethanol precipitation is used to remove large molecular weight polysaccharides and proteins, and to extract the target emblica water-soluble small molecules.
[0066] In A1, the antimicrobial properties of water-soluble small molecule extracts of Phyllanthus emblica were discovered.
[0067] In A2, a Waters ACQUITY™ Premier HSST3 column was used to achieve better separation.
[0068] In A2, the analytical identification method is:
[0069] Firstly, the data on the chemical components of Phyllanthus emblica were obtained by consulting the literature, and the structures of the chemical components were input into the Compound Discover software to establish a primary database for comparison. At the same time, the Traditional Chinese Medicine Components High Resolution Mass Spectrum Database (OTCML) was imported to establish a local secondary database for secondary fragment comparison. The online search of the primary data resource library ChemSpider and the secondary data resource library MzCloud was combined to analyze and compare the components.
[0070] Then, the accurate mass, mass spectrometry fragments and characteristic fragment ions of the compounds in the HMDB and PMhub databases were used to make judgments and determine the final screening results.
[0071] The invention also provides a water-soluble small molecule of Phyllanthus emblica, comprising an extract obtained through a component extraction process of the water-soluble small molecule of Phyllanthus emblica.
[0072] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. A process for extracting and identifying components of water-soluble small molecules from Phyllanthus emblica, characterized in that: The following steps are involved: S1. Pretreatment of Phyllanthus emblica fruit The fruit of Phyllanthus emblica was crushed, weighed, and added with ultrapure water at a ratio of 1 g:10 mL, heated for water extraction, centrifuged, and filtered through a membrane; S2. Extraction of water-soluble small molecules from Phyllanthus emblica Add high concentration anhydrous ethanol to the supernatant after centrifugal filtration, seal and let stand overnight at 4°C, centrifuge and filter the alcohol precipitated sample, heat and evaporate to remove ethanol and water, add ultrapure water again according to the volume of the original water extract, stir and heat to dissolve, filter through the membrane to obtain the water-soluble small molecule extract of Phyllanthus emblica, and refrigerate at 4°C.
2. The process for extracting and identifying the components of water-soluble small molecules from Phyllanthus emblica as claimed in claim 1, characterized in that: The analysis of the water-soluble small molecule extract of Phyllanthus emblica consists of the following steps: A1. Antibacterial function analysis The water-soluble small molecule extract was diluted twice with LB liquid medium for later use. After activating the strain by streaking on LB solid plate, a single colony was picked and transferred to 0.9% saline solution. The concentration of the bacterial solution was adjusted to 0.5 McFarland concentration (1.5×10 8 CFU / mL), diluted 100 times, added the diluted bacterial solution to each diluted concentration solution in a 96-well plate, repeated 3 times in each group, with LB medium as blank control, shaken slightly and cultured at 37℃ for 18-24 hours, observed bacterial growth, and compared OD before and after culture. 600 Value changes; A2. Identification and analysis of water-soluble small molecule components of Phyllanthus emblica Chromatographic conditions: A Waters ACQUITYTM Premier HSS T3 column with specifications of 2.1 mm × 100 mm, 1.8 μm was used; 0.1% formic acid aqueous solution was used as mobile phase A, and methanol was used as mobile phase B for gradient elution; Positive ion mode: 0-12 min, 0%-3% B; 12-17 min, 3%-40% B; 17-25 min, 40%-45% B; 25-30 min, 45%-65% B; 30-40 min, 65%-100% B; 40-45 min, 100%-0% B; Negative ion mode: 0-18 min, 0%-5% B; 18-20 min, 5%-40% B; 20-25 min, 40%-42% B; 25-30 min, 42%-100% B; 30-35 min, 100-0% B; flow rate 0.3 mL / min, column temperature 30°C, injection volume 3 μL; the above concentrations are all volume percentages; Mass spectrometry conditions: ESI electrospray ion source was used, nitrogen was used as drying, nebulizing and collision gas, data were collected in positive and negative ion modes, and the acquisition conditions for both modes were ion source temperature of 350°C, capillary temperature of 320°C, spray voltage of 3.8 kV, sheath gas flow rate of 30 L / h, auxiliary gas flow rate of 15 L / h, capillary voltage of 35 V, tube lens voltage of 110 V, primary resolution of 70000, secondary resolution of 17500, stepped NCE 20, 40, 60, and the mass range of m / z 50-1500 was scanned in MS and MS / MS modes to record spectra. Secondary mass spectrometry used data-dependent scanning, and the ion accurate molecular weights of water-soluble substances of Phyllanthus emblica recorded in multiple literatures were selected for collision-induced dissociation (CID) fragment scanning; The data collected by mass spectrometry were analyzed to identify the water-soluble small molecule components of the Tibetan medicine Phyllanthus emblica.
3. The process for extracting and identifying the components of water-soluble small molecules from Phyllanthus emblica as claimed in claim 1, characterized in that: In S1, the centrifugation parameters are 12000g for 60 min to separate and precipitate macromolecular polysaccharides and proteins with greater efficiency.
4. The process for extracting and identifying the components of water-soluble small molecules from Phyllanthus emblica as claimed in claim 1, characterized in that: In S1, water extraction was used for extraction, the ratio of emblica emblica to water was 1 g:10 mL, and the extraction time was 2 h.
5. The process for extracting and identifying the components of water-soluble small molecules from Phyllanthus emblica as claimed in claim 1, characterized in that: In S2, high concentration ethanol precipitation is used to remove large molecular weight polysaccharides and proteins, and to extract the target emblica water-soluble small molecules.
6. The process for extracting and identifying the components of water-soluble small molecules from Phyllanthus emblica as claimed in claim 2, characterized in that: In A1, the antimicrobial properties of water-soluble small molecule extracts of Phyllanthus emblica were discovered.
7. The process for extracting and identifying the components of water-soluble small molecules from Phyllanthus emblica as claimed in claim 2, characterized in that: In A2, a Waters ACQUITY™ Premier HSS T3 column was used to achieve better separation.
8. The process for extracting and identifying the components of water-soluble small molecules from Phyllanthus emblica as claimed in claim 2, characterized in that: In A2, the analysis and identification method is: Firstly, the data on the chemical components of Phyllanthus emblica were obtained by consulting the literature, and the structures of the chemical components were input into the Compound Discover software to establish a primary database for comparison. At the same time, the Traditional Chinese Medicine Components High Resolution Mass Spectrum Database (OTCML) was imported to establish a local secondary database for secondary fragment comparison. The online search of the primary data resource library ChemSpider and the secondary data resource library MzCloud was combined to analyze and compare the components. Then, the accurate mass, mass spectrometry fragments and characteristic fragment ions of the compounds in the HMDB and PMhub databases were used to make judgments and determine the final screening results.
9. The process for extracting and identifying the components of water-soluble small molecules from Phyllanthus emblica as claimed in claim 2, characterized in that: It is characterized in that The invention relates to an extract obtained by the extraction process of the water-soluble small molecule components of Phyllanthus emblica according to claims 1-8.
Citation Information
Patent Citations
Preparation method of emblic leafflower fruit polysaccharide
CN110698570A
Method for detecting multiple components in Tibetan medicine twenty-five-ingredient big decoction pill
CN117250300A
